Related references
Note: Only part of the references are listed.Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems
Shinjiro Saito et al.
JOURNAL OF CRITICAL CARE (2019)
Sensitive mass spectrometric assay for determination of 15-deoxy-Delta(12,14)-prostaglandin J(2) and its application in human plasma samples of patients with diabetes
Jakob Morgenstern et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2018)
Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis
Kota Hoshino et al.
JOURNAL OF INTENSIVE CARE (2017)
Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients
Hunter B. Moore et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2016)
Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials
Y. Umemura et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan
Kazuma Yamakawa et al.
CRITICAL CARE (2016)
The Efficacy and Safety of Heparin in Patients With Sepsis: A Systematic Review and Metaanalysis
Ryan Zarychanski et al.
CRITICAL CARE MEDICINE (2015)
Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography
Mauro Panigada et al.
PLOS ONE (2015)
Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
Jumpei Yoshimura et al.
CRITICAL CARE (2015)
Crosstalk between the coagulation and complement systems in sepsis
Florea Lupu et al.
THROMBOSIS RESEARCH (2014)
Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review
Marcella C. Muller et al.
CRITICAL CARE (2014)
The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients
I. Roberts et al.
HEALTH TECHNOLOGY ASSESSMENT (2013)
Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: A prospective study
Sisse R. Ostrowski et al.
JOURNAL OF CRITICAL CARE (2013)
Role of Fibrinolysis in Sepsis
Satoshi Gando
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation
Toshiaki Iba et al.
THROMBOSIS RESEARCH (2013)
Viscoelastic and aggregometric point-of-care testing in patients with septic shock - cross-links between inflammation and haemostasis
T. Brenner et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2012)
Severe sepsis, coagulation, and fibrinolysis: Dead end or one way?
Francois Fourrier
CRITICAL CARE MEDICINE (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Epidemiology and pathophysiology of cancer-associated thrombosis
S. Noble et al.
BRITISH JOURNAL OF CANCER (2010)
Inflammatory Cytokine Response to Bacillus anthracis Peptidoglycan Requires Phagocytosis and Lysosomal Trafficking
Janaki K. Iyer et al.
INFECTION AND IMMUNITY (2010)
Cellular sources of tissue factor in endotoxemia and sepsis
Rafal Pawlinski et al.
THROMBOSIS RESEARCH (2010)
Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults
Michael Adamzik et al.
CRITICAL CARE (2010)
Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation
Mirka Sivula et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
Early intravenous unfractionated heparin and mortality in septic shock
Ryan Zarychanski et al.
CRITICAL CARE MEDICINE (2008)
Thrombocytopenia in Critically Ill Patients
Marcel Levi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Fibrin and fibrinolysis in infection and host defense
J. L. Degen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the International Society on Thrombosis and Haemostasis: A 5-year overview
C. H. Toh et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Complement and coagulation: strangers or partners in crime?
Maciej M. Markiewski et al.
TRENDS IN IMMUNOLOGY (2007)
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety
CJ Wiedermann et al.
CRITICAL CARE MEDICINE (2006)
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
J Kienast et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Disseminated intravascular coagulation in sepsis
S Zeerleder et al.
CHEST (2005)
Platelet function in sepsis
A Yaguchi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Sepsis and disseminated intravascular coagulation
M Levi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2003)
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
E Abraham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis
SM Opal et al.
CRITICAL CARE (2003)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial
BL Warren et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
